NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
18/02/2026
Voltar para busca
Dado oficial do USPTO
CHO.RIGHT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CHO.RIGHT
ST13
US500000079232855Classe
1, 5, 9, 40, 42
Pedido
79232855
Registro
5724306
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
30
Atualização mais recente
10/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 40, 42
Data de depósito
05/04/2018
Data de registro
16/04/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
18/02/2026
Última transação
10/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
708
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
Berlin, DE
Examinador
GANESH, HARINI
Localização atual
Historical data usage
Titulares e representantes
Titulares
ProBioGen AG
ProBioGen AG
Representantes
David A.W. Wong Barnes & Thornburg LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Protein expression systemshuman proteins for life science and medical research
Classe 5
Biological preparations for diagnosticpharmaceutical and veterinary purposesin particular biological preparations developed from biological cells and for use in the extractionpropagation or modification of biological cells and for the manufacture of biological active substancesbacterial enzymes; enzymes for medical purposes
Classe 9
Laboratory apparatus and instrumentshomogenizers and systems for use in protein purification; laboratory apparatusdevices for analyzing protein sequence; bioreactors for laboratory use
Classe 40
Custom manufacture of pharmaceuticals by pharmaceutical compounders; custom manufacture of pharmaceuticals using biological organisms in the manufacturing process; custom manufacture of proteins and vaccines with the aid of biological cellsincluding cell design and modification of biological cells; custom manufacture of biological active substances and bacterial enzymes
Classe 42
Research and development in the fields of bacteriologycellular engineeringcytologyantibodiesglycomicschemistrymicroorganismsproteinsimmunologybiological therapeuticsnutraceuticals and gene expression systems; scientific research and genome synthesis services for others; scientific and technological servicesresearch services in the fields of geneticsepigenetics and expression analysis; research and development in the biotechnology fieldsconducting protein expression; scientific and industrial research in the fields of medicinepharmacymolecular biologybiotechnology and genetics; research and development of drugsdiagnostic and analytical preparationstherapy procedures and expression systemsprotein expression systems; biotechnological research relating to enzymatic synthesis; biochemistry servicesbiochemical assays and DNA screening; research relating to biotechnology; consultancy services relating to biotechnology; design services relating to process systems for the biotechnology industry; design services relating to plants for the biotechnology industry; research and development in the pharmaceutical and biotechnology fields; scientific and industrial research and development in the field of biotechnology and protein expression systems; biological research; laboratory services in connection with the use of bacterial enzymes for synthesis purposes; medical laboratory servicespropagation or modification of biological cells
Publicações
Histórico de despachos e eventos da marca no USPTO.
30 publicações encontradas
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
18/02/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/02/2026
ES75
TEAS SECTION 71 & 15 RECEIVED
13/10/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
16/04/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
30/08/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/08/2019
FIMP
FINAL DISPOSITION PROCESSED
08/08/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
16/07/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
16/04/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29/01/2019
PUBO
PUBLISHED FOR OPPOSITION
29/01/2019
GPNX
NOTIFICATION PROCESSED BY IB
25/01/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/01/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/01/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/01/2019
ALIE
ASSIGNED TO LIE
21/12/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/11/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/11/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/11/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/11/2018
RFNP
REFUSAL PROCESSED BY IB
31/08/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
16/08/2018
RFRR
REFUSAL PROCESSED BY MPU
16/08/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/07/2018
CNRT
NON-FINAL ACTION WRITTEN
27/07/2018
DOCK
ASSIGNED TO EXAMINER
23/07/2018
MAFR
APPLICATION FILING RECEIPT MAILED
05/06/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
31/05/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
24/05/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CHO.RIGHT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.